177 related articles for article (PubMed ID: 18513786)
1. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
Devine KM; Smicun Y; Hope JM; Fishman DA
Gynecol Oncol; 2008 Aug; 110(2):237-45. PubMed ID: 18513786
[TBL] [Abstract][Full Text] [Related]
2. S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells.
Smicun Y; Gil O; Devine K; Fishman DA
Gynecol Oncol; 2007 Nov; 107(2):298-309. PubMed ID: 17716713
[TBL] [Abstract][Full Text] [Related]
3. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
4. S1P regulation of ovarian carcinoma invasiveness.
Smicun Y; Reierstad S; Wang FQ; Lee C; Fishman DA
Gynecol Oncol; 2006 Dec; 103(3):952-9. PubMed ID: 16956652
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61.
Young N; Pearl DK; Van Brocklyn JR
Mol Cancer Res; 2009 Jan; 7(1):23-32. PubMed ID: 19147534
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.
Gil OD; Lee C; Ariztia EV; Wang FQ; Smith PJ; Hope JM; Fishman DA
Gynecol Oncol; 2008 Feb; 108(2):361-9. PubMed ID: 18073130
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
[TBL] [Abstract][Full Text] [Related]
9. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.
Arikawa K; Takuwa N; Yamaguchi H; Sugimoto N; Kitayama J; Nagawa H; Takehara K; Takuwa Y
J Biol Chem; 2003 Aug; 278(35):32841-51. PubMed ID: 12810709
[TBL] [Abstract][Full Text] [Related]
10. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Wang FQ; Smicun Y; Calluzzo N; Fishman DA
Mol Cancer Res; 2006 Nov; 4(11):831-41. PubMed ID: 17114341
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
So J; Navari J; Wang FQ; Fishman DA
Gynecol Oncol; 2004 Nov; 95(2):314-22. PubMed ID: 15491751
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform.
Sugimoto N; Takuwa N; Okamoto H; Sakurada S; Takuwa Y
Mol Cell Biol; 2003 Mar; 23(5):1534-45. PubMed ID: 12588974
[TBL] [Abstract][Full Text] [Related]
14. LPA and S1P increase corneal epithelial and endothelial cell transcellular resistance.
Yin F; Watsky MA
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1927-33. PubMed ID: 15914605
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.
Okamoto H; Takuwa N; Yokomizo T; Sugimoto N; Sakurada S; Shigematsu H; Takuwa Y
Mol Cell Biol; 2000 Dec; 20(24):9247-61. PubMed ID: 11094076
[TBL] [Abstract][Full Text] [Related]
16. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
[TBL] [Abstract][Full Text] [Related]
17. S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells.
Wang D; Zhao Z; Caperell-Grant A; Yang G; Mok SC; Liu J; Bigsby RM; Xu Y
Mol Cancer Ther; 2008 Jul; 7(7):1993-2002. PubMed ID: 18645009
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration.
Panetti TS; Nowlen J; Mosher DF
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1013-9. PubMed ID: 10764666
[TBL] [Abstract][Full Text] [Related]
19. S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells.
Park KS; Kim MK; Lee HY; Kim SD; Lee SY; Kim JM; Ryu SH; Bae YS
Biochem Biophys Res Commun; 2007 Apr; 356(1):239-44. PubMed ID: 17349972
[TBL] [Abstract][Full Text] [Related]
20. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Li H; Ye X; Mahanivong C; Bian D; Chun J; Huang S
J Biol Chem; 2005 Mar; 280(11):10564-71. PubMed ID: 15653692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
